147 related articles for article (PubMed ID: 38783409)
1. Peanut oral immunotherapy using an extensively heated and baked novel composition of peanuts.
Kidon MI; Shavit R; Levy Y; Haj Yahia S; Machnes-Maayan D; Frizinsky S; Maoz-Segal R; Offenganden I; Kenett RS; Nancy AL; Hovav R
Pediatr Allergy Immunol; 2024 May; 35(5):e14146. PubMed ID: 38783409
[TBL] [Abstract][Full Text] [Related]
2. Allergen-specific oral immunotherapy for peanut allergy.
Nurmatov U; Venderbosch I; Devereux G; Simons FE; Sheikh A
Cochrane Database Syst Rev; 2012 Sep; (9):CD009014. PubMed ID: 22972130
[TBL] [Abstract][Full Text] [Related]
3. Probiotic peanut oral immunotherapy versus oral immunotherapy and placebo in children with peanut allergy in Australia (PPOIT-003): a multicentre, randomised, phase 2b trial.
Loke P; Orsini F; Lozinsky AC; Gold M; O'Sullivan MD; Quinn P; Lloyd M; Ashley SE; Pitkin S; Axelrad C; Metcalfe JR; Su EL; Tey D; Robinson MN; Allen KJ; Prescott SL; Galvin AD; Tang MLK;
Lancet Child Adolesc Health; 2022 Mar; 6(3):171-184. PubMed ID: 35123664
[TBL] [Abstract][Full Text] [Related]
4. High Degree of Desensitization After 1 Year of Early-Life Peanut Oral Immunotherapy: Small Children Oral Immunotherapy (SmaChO) Randomized Controlled Trial.
Uhl C; Klevebro S; Sverremark-Ekström E; Tedner SG; Brandström J; Papageorgiou C; Melén E; Konradsen JR; Nilsson C; Asarnoj A
J Allergy Clin Immunol Pract; 2024 May; 12(5):1297-1305. PubMed ID: 38428524
[TBL] [Abstract][Full Text] [Related]
5. A randomized, double-blind, placebo-controlled pilot study of sublingual versus oral immunotherapy for the treatment of peanut allergy.
Narisety SD; Frischmeyer-Guerrerio PA; Keet CA; Gorelik M; Schroeder J; Hamilton RG; Wood RA
J Allergy Clin Immunol; 2015 May; 135(5):1275-82.e1-6. PubMed ID: 25528358
[TBL] [Abstract][Full Text] [Related]
6. Feasibility of desensitizing children highly allergic to peanut by high-dose oral immunotherapy.
Reier-Nilsen T; Michelsen MM; Lødrup Carlsen KC; Carlsen KH; Mowinckel P; Nygaard UC; Namork E; Borres MP; Håland G
Allergy; 2019 Feb; 74(2):337-348. PubMed ID: 30225844
[TBL] [Abstract][Full Text] [Related]
7. Oral immunotherapy using boiled peanuts for treating peanut allergy: An open-label, single-arm trial.
Grzeskowiak LE; Tao B; Aliakbari K; Chegeni N; Morris S; Chataway T
Clin Exp Allergy; 2023 Mar; 53(3):327-336. PubMed ID: 36628520
[TBL] [Abstract][Full Text] [Related]
8. Early oral immunotherapy in peanut-allergic preschool children is safe and highly effective.
Vickery BP; Berglund JP; Burk CM; Fine JP; Kim EH; Kim JI; Keet CA; Kulis M; Orgel KG; Guo R; Steele PH; Virkud YV; Ye P; Wright BL; Wood RA; Burks AW
J Allergy Clin Immunol; 2017 Jan; 139(1):173-181.e8. PubMed ID: 27522159
[TBL] [Abstract][Full Text] [Related]
9. Oral immunotherapy for children with a high-threshold peanut allergy.
Haj Yahia S; Machnes-Maayan D; Frizinsky S; Maoz-Segal R; Offenganden I; Kenett RS; Agmon-Levin N; Hovav R; Kidon MI
Ann Allergy Asthma Immunol; 2022 Sep; 129(3):347-353. PubMed ID: 35552009
[TBL] [Abstract][Full Text] [Related]
10. A pilot study of omalizumab to facilitate rapid oral desensitization in high-risk peanut-allergic patients.
Schneider LC; Rachid R; LeBovidge J; Blood E; Mittal M; Umetsu DT
J Allergy Clin Immunol; 2013 Dec; 132(6):1368-74. PubMed ID: 24176117
[TBL] [Abstract][Full Text] [Related]
11. Parent and child perception of quality of life in a randomized controlled peanut oral immunotherapy trial.
Reier-Nilsen T; Carlsen KCL; Michelsen MM; Drottning S; Carlsen KH; Zhang C; Borres MP; Håland G
Pediatr Allergy Immunol; 2019 Sep; 30(6):638-645. PubMed ID: 31013372
[TBL] [Abstract][Full Text] [Related]
12. Clinical efficacy and immune regulation with peanut oral immunotherapy.
Jones SM; Pons L; Roberts JL; Scurlock AM; Perry TT; Kulis M; Shreffler WG; Steele P; Henry KA; Adair M; Francis JM; Durham S; Vickery BP; Zhong X; Burks AW
J Allergy Clin Immunol; 2009 Aug; 124(2):292-300, 300.e1-97. PubMed ID: 19577283
[TBL] [Abstract][Full Text] [Related]
13. Assessing the efficacy of oral immunotherapy for the desensitisation of peanut allergy in children (STOP II): a phase 2 randomised controlled trial.
Anagnostou K; Islam S; King Y; Foley L; Pasea L; Bond S; Palmer C; Deighton J; Ewan P; Clark A
Lancet; 2014 Apr; 383(9925):1297-1304. PubMed ID: 24485709
[TBL] [Abstract][Full Text] [Related]
14. Assessing the efficacy of oral immunotherapy for the desensitisation of peanut allergy in children (STOP II): a phase 2 randomised controlled trial: a critical appraisal.
Marrs T; Flohr C; Perkin MR
Br J Dermatol; 2015 Nov; 173(5):1125-9. PubMed ID: 26769642
[TBL] [Abstract][Full Text] [Related]
15. Long-term outcome of peanut oral immunotherapy-Real-life experience.
Nachshon L; Goldberg MR; Katz Y; Levy MB; Elizur A
Pediatr Allergy Immunol; 2018 Aug; 29(5):519-526. PubMed ID: 29698554
[TBL] [Abstract][Full Text] [Related]
16. Peanut Allergen Threshold Study (PATS): Novel single-dose oral food challenge study to validate eliciting doses in children with peanut allergy.
Hourihane JO; Allen KJ; Shreffler WG; Dunngalvin G; Nordlee JA; Zurzolo GA; Dunngalvin A; Gurrin LC; Baumert JL; Taylor SL
J Allergy Clin Immunol; 2017 May; 139(5):1583-1590. PubMed ID: 28238744
[TBL] [Abstract][Full Text] [Related]
17. Low-dose oral immunotherapy for children with anaphylactic peanut allergy in Japan.
Nagakura KI; Yanagida N; Sato S; Nishino M; Asaumi T; Ogura K; Ebisawa M
Pediatr Allergy Immunol; 2018 Aug; 29(5):512-518. PubMed ID: 29603410
[TBL] [Abstract][Full Text] [Related]
18. The safety of peanut oral immunotherapy in peanut-allergic subjects in a single-center trial.
Yu GP; Weldon B; Neale-May S; Nadeau KC
Int Arch Allergy Immunol; 2012; 159(2):179-82. PubMed ID: 22678151
[TBL] [Abstract][Full Text] [Related]
19. Oral immunotherapy for peanut allergy: multipractice experience with epinephrine-treated reactions.
Wasserman RL; Factor JM; Baker JW; Mansfield LE; Katz Y; Hague AR; Paul MM; Sugerman RW; Lee JO; Lester MR; Mendelson LM; Nacshon L; Levy MB; Goldberg MR; Elizur A
J Allergy Clin Immunol Pract; 2014; 2(1):91-6. PubMed ID: 24565775
[TBL] [Abstract][Full Text] [Related]
20. Efficacy, Safety, and Quality of Life in a Multicenter, Randomized, Placebo-Controlled Trial of Low-Dose Peanut Oral Immunotherapy in Children with Peanut Allergy.
Blumchen K; Trendelenburg V; Ahrens F; Gruebl A; Hamelmann E; Hansen G; Heinzmann A; Nemat K; Holzhauser T; Roeder M; Rosenfeld L; Hartmann O; Niggemann B; Beyer K
J Allergy Clin Immunol Pract; 2019 Feb; 7(2):479-491.e10. PubMed ID: 30423449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
